Siloam International Hospitals Valuation

Is SILO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SILO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SILO (IDR3060) is trading above our estimate of fair value (IDR1462.55)

Significantly Below Fair Value: SILO is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SILO?

Key metric: As SILO is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SILO. This is calculated by dividing SILO's market cap by their current earnings.
What is SILO's PE Ratio?
PE Ratio	38.9x
Earnings	Rp1.02t
Market Cap	Rp39.73t

SILO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.4x
Enterprise Value/EBITDA	17.3x
PEG Ratio	2.6x

Price to Earnings Ratio vs Peers

How does SILO's PE Ratio compare to its peers?

The above table shows the PE ratio for SILO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	70.2x
MIKA Mitra Keluarga Karyasehat	33x	13.7%	Rp36.4t
HEAL Medikaloka Hermina	37.3x	15.0%	Rp20.8t
PRAY Famon Awal Bros Sedaya	33.6x	n/a	Rp8.7t
BMHS Bundamedik	176.7x	n/a	Rp2.3t
SILO Siloam International Hospitals	38.9x	14.7%	Rp39.7t

Price-To-Earnings vs Peers: SILO is good value based on its Price-To-Earnings Ratio (38.9x) compared to the peer average (70.2x).

Price to Earnings Ratio vs Industry

How does SILO's PE Ratio compare vs other companies in the Asian Healthcare Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: SILO is expensive based on its Price-To-Earnings Ratio (38.9x) compared to the Asian Healthcare industry average (21.2x).

Price to Earnings Ratio vs Fair Ratio

What is SILO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SILO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	38.9x
Fair PE Ratio	35x

Price-To-Earnings vs Fair Ratio: SILO is expensive based on its Price-To-Earnings Ratio (38.9x) compared to the estimated Fair Price-To-Earnings Ratio (35x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SILO forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	Rp3,060.00	Rp3,290.00 +7.5%	11.5%	Rp4,000.00	Rp2,770.00	n/a	10
Nov ’25	Rp3,080.00	Rp3,168.00 +2.9%	11.0%	Rp4,000.00	Rp2,770.00	n/a	10
Oct ’25	Rp3,100.00	Rp3,143.64 +1.4%	10.9%	Rp4,000.00	Rp2,770.00	n/a	11
Sep ’25	Rp2,820.00	Rp2,984.00 +5.8%	6.0%	Rp3,300.00	Rp2,760.00	n/a	10
Aug ’25	Rp2,710.00	Rp2,974.00 +9.7%	6.0%	Rp3,300.00	Rp2,760.00	n/a	10
Jul ’25	Rp2,790.00	Rp2,905.56 +4.1%	6.3%	Rp3,300.00	Rp2,700.00	n/a	9
Jun ’25	Rp2,420.00	Rp2,905.56 +20.1%	6.3%	Rp3,300.00	Rp2,700.00	n/a	9
May ’25	Rp2,400.00	Rp2,764.44 +15.2%	17.4%	Rp3,300.00	Rp1,500.00	n/a	9
Apr ’25	Rp2,480.00	Rp2,810.56 +13.3%	17.5%	Rp3,300.00	Rp1,500.00	n/a	9
Mar ’25	Rp2,310.00	Rp2,766.88 +19.8%	18.3%	Rp3,300.00	Rp1,500.00	n/a	8
Feb ’25	Rp2,310.00	Rp2,671.67 +15.7%	20.5%	Rp3,300.00	Rp1,500.00	n/a	9
Jan ’25	Rp2,180.00	Rp2,569.50 +17.9%	23.5%	Rp3,300.00	Rp1,500.00	n/a	10
Dec ’24	Rp2,220.00	Rp2,605.00 +17.3%	19.8%	Rp3,300.00	Rp1,650.00	n/a	9
Nov ’24	Rp2,410.00	Rp2,527.22 +4.9%	20.6%	Rp3,300.00	Rp1,650.00	Rp3,080.00	9
Oct ’24	Rp2,040.00	Rp2,152.78 +5.5%	11.7%	Rp2,565.00	Rp1,650.00	Rp3,100.00	9
Sep ’24	Rp1,950.00	Rp2,146.88 +10.1%	12.4%	Rp2,565.00	Rp1,650.00	Rp2,820.00	8
Aug ’24	Rp1,860.00	Rp2,177.50 +17.1%	13.3%	Rp2,565.00	Rp1,650.00	Rp2,710.00	6
Jul ’24	Rp1,875.00	Rp1,902.14 +1.4%	13.6%	Rp2,170.00	Rp1,400.00	Rp2,790.00	7
Jun ’24	Rp1,650.00	Rp1,902.14 +15.3%	13.6%	Rp2,170.00	Rp1,400.00	Rp2,420.00	7
May ’24	Rp1,730.00	Rp1,654.38 -4.4%	24.4%	Rp2,170.00	Rp1,050.00	Rp2,400.00	8
Apr ’24	Rp1,515.00	Rp1,391.88 -8.1%	17.8%	Rp1,735.00	Rp1,050.00	Rp2,480.00	8
Mar ’24	Rp1,330.00	Rp1,314.38 -1.2%	12.7%	Rp1,590.00	Rp1,050.00	Rp2,310.00	8
Feb ’24	Rp1,255.00	Rp1,292.14 +3.0%	12.9%	Rp1,590.00	Rp1,050.00	Rp2,310.00	7
Jan ’24	Rp1,260.00	Rp1,268.13 +0.6%	13.3%	Rp1,590.00	Rp1,050.00	Rp2,180.00	8
Dec ’23	Rp1,280.00	Rp1,280.63 +0.05%	14.1%	Rp1,590.00	Rp1,050.00	Rp2,220.00	8
Nov ’23	Rp1,130.00	Rp1,280.63 +13.3%	14.1%	Rp1,590.00	Rp1,050.00	Rp2,410.00	8

Analyst Forecast: Target price is less than 20% higher than the current share price.